Moritoyo Takashi

モリトヨタカシ | Moritoyo Takashi

Affiliation and department：
Job title： Professor

Research field (2)： Neurology , Pharmacology

Research keywords (3)： Neurology , Clinical Pharmacology , Regulatory Science

Papers (71)：

Kuniyasu Niizuma, Naoko Nishimura, Keiko Hasegawa, Takashi Moritoyo, Kohsuke Kudo, Josh Bell, Michael Wald, Yoshifumi Umeda, Kazuhiko Kuribayashi, Yasuo Toda, et al. Anti-Inflammatory Thrombolytic JX10 (TMS-007) in Late Presentation of Acute Ischemic Stroke. Stroke. 2024. 55. 12. 2786-2794
Miki Ohta, Satoru Miyawaki, Shinichiroh Yokota, Makoto Yoshimoto, Tatsuya Maruyama, Daisuke Koide, Takashi Moritoyo, Nobuhito Saito. Causality Assessment Between Drugs and Fatal Cerebral Haemorrhage Using Electronic Medical Records: Comparative Evaluation of Disease-Specific and Conventional Methods. Drugs - real world outcomes. 2024. 11. 2. 221-229
Shu Okugawa, Mahoko Ikeda, Kosuke Kashiwabara, Takashi Moritoyo, Takao Kohsaka, Toshio Shimizu, Hideharu Hagiya, Kou Hasegawa, Fumio Otsuka, Ayumi Miwa, et al. Antiviral effect and safety of nafamostat mesilate in patients with mild early-onset COVID-19: An exploratory multicentre randomized controlled clinical trial. International journal of antimicrobial agents. 2023. 62. 3. 106922-106922
Takashi Moritoyo, Naoko Nishimura, Keiko Hasegawa, Shinya Ishii, Kenji Kirihara, Munenori Takata, Akiko Kishi Svensson, Yumi Umeda-Kameyama, Shuichi Kawarasaki, Ryoko Ihara, et al. A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenol. British journal of clinical pharmacology. 2023. 89. 6. 1809-1819
Jun Mitsui, Takashi Matsukawa, Yukari Uemura, Takuya Kawahara, Ayaka Chikada, Kristine Joyce L Porto, Hiroya Naruse, Masaki Tanaka, Hiroyuki Ishiura, Tatsushi Toda, et al. High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial. EClinicalMedicine. 2023. 59. 101920-101920

ｍore...

MISC (222)：

太田実紀, 河原崎秀一, 藤田真由, 橋本純子, 森谷純治, 小出大介, 吉本真, 井口豊崇, 森豊隆志. 医薬品と致死的頭蓋内出血の因果関係評価~副作用疑い報告を用いた検討~. レギュラトリーサイエンス学会誌. 2024. 14. Supplement
森豊隆志. PMDAでの経験とその後~アカデミアの臨床研究推進への貢献~. 神経治療学. 2024. 41. 3. 410-410
森豊隆志. AROを活用して推進するアカデミアの臨床研究. 日本環境感染学会総会・学術集会(Web). 2023. 38th
森豊隆志. AROとは何か,AROが支えるアカデミアの研究開発. 日本神経学会学術大会プログラム・抄録集. 2023. 64th
和田育江, 徳山友希乃, 平野麻理, 藤野悟央, 森豊隆志, 北村明日香, 高橋朗子, 小牧宏文, 小林千浩, 池田(谷口) 真理子, et al. 希少難病小児を対象とした第Ι相医師主導治験における患者リクルート. 日本臨床薬理学会学術総会抄録集. 2023. 44. 1-C-P-F1

ｍore...

Education (1)：

- 1986 Kagoshima University Faculty of Medicine

Professional career (1)：

M.D., Ph.D. (Kagoshima University)

Work history (13)：

2025/04 - Teikyo University Teikyo Academic Research Center Professor
2021/04 - The University of Tokyo Hospital Assistant Director (Clinical Research)
2018/04 - The University of Tokyo Hospital Clinical Research Promotion Center Professor/Director
2015/08 - The University of Tokyo Hospital Department of Clinical Research Governance Project Professor/Director
2015/04 - The University of Tokyo Hospital Clinical Research Support Center Associate Professor/Deputy Director

Show all

Committee career (13)：

2021 - 一般社団法人大学病院臨床試験アライアンス理事
2020 - 厚生労働省医薬品等行政評価・監視委員会委員
2018 - ARO協議会理事
2018 - 国立大学附属病院臨床研究推進会議代表幹事
2018 - 日本臨床薬理学会監事

Show all

Association Membership(s) (12)：

JAPAN SOCIETY FOR DEMENTIA RESEARCH , 日本神経治療学会 , 日本臨床薬理学会 , 日本癌学会 , 日本分子生物学会 , 日本生理学会 , 日本サイトメトリー学会 , 日本リハビリテーション医学会 , American Academy of Neurology , 日本臨床神経生理学会 , 日本内科学会 , 日本神経学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page